• About us
• Contact

Advertisement

Organisation › Details

Dermira, Inc. (Nasdaq: DERM)

Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. Dermira is committed to understanding the needs of both patients and physicians and using its insight to identify, develop and commercialize leading-edge medical dermatology products. The company's approved treatment, QBREXZA® (glycopyrronium) cloth, is indicated for pediatric and adult patients (ages 9 and older) with primary axillary hyperhidrosis (excessive underarm sweating). Please see the QBREXZA prescribing information. Dermira is currently evaluating lebrikizumab in a Phase 3 clinical development program for the treatment of moderate-to-severe atopic dermatitis (a form of eczema) and also has early-stage research and development programs in other areas of dermatology. Dermira is headquartered in Menlo Park, Calif. *

 

	Start	2015-12-01 existent
	Group	Eli Lilly (Group)
	Region	Menlo Park, CA
	Country	United States (USA)
	Street	275 Middlefield Road Suite 150
	City	94025 Menlo Park, CA
	Tel	+1-650-421-7200
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Eli Lilly and Company. (1/10/20). "Press Release: Lilly Announces Agreement to Acquire Dermira". Indianapolis, IN & Menlo Park, CA.
		Record changed: 2023-07-10

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.